Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Zoetis Inc. ZTS

Healthcare  —  Drug Manufacturers Specialty & Generic
71.05 0.78 1.11% as of 25 Sep
Market cap
$29.2B
P/E
11.7×
S&P 500 Member Dividend Champion (10y) Revenue Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Zoetis Inc. (ZTS) Book value per share

Zoetis Inc.'s book value per share at the end of fiscal 2025 was 7.5×, down 28.5% from 10.5× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 7.5×. Over the past ten years it has ranged from 2.2× (fiscal 2015) to 10.8× (fiscal 2023); the current reading is higher than 55% of that period. Zoetis Inc. ranks 24th of 86 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 7.5× (28.47%)
FY2024 10.5× (2.96%)
FY2023 10.8× 15.25%
FY2022 9.4× (1.98%)
FY2021 9.6× 20.73%
FY2020 7.9× 40.10%
FY2019 5.7× 25.22%
FY2018 4.5× 24.08%
FY2017 3.6× 20.56%
FY2016 3.0× 38.50%

Quarterly

Period Book value per share Change
Jun 2026 7.5× (1.58%)
Mar 2026 7.7× (0.54%)
Dec 2025 7.7× (36.81%)
Sep 2025 12.2× 9.00%
42 more quarters

Against its own ten years

Low 2.2× High 10.8×
Ten-year median 7.5×
Current reading's percentile 55

Book value per share against peers

Company Book value per share
UTHR United Therapeutics Corporation compare 150×
NBIX Neurocrine Biosciences, Inc. compare 36.6×
TAK Takeda Pharmaceutical Co. compare 15.1×
ELAN Elanco Animal Health Incorporated compare 13.2×
VTRS Viatris Inc. compare 12.3×
ZTS Zoetis Inc. 7.5×
TEVA Teva Pharmaceutical Industries Ltd. compare 6.7×
RDY Dr. Reddy's Laboratories Ltd compare 5.2×
HLN Haleon PLC Sponsored ADR compare 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on ZTS